Abstract

and 82% &79%, respectively. Vaginal extension was the only negative predictor factor for the loco regional control (p5 0.045), while the grade was the only factor for the distant metastases free survival (p5 0.037). Grade 3 or 4 late rectal reaction was reported in 2 patients (3%), severe vaginal adhesion in one patient (1.5%), while no patients developed grade 3 or 4 urinary reaction Conclusions: Our study confirmed the efficacy of using concurrent chemoradiotherapy incorporating the HDR-BT in the treatment of cervix uteri cancer patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call